Table 1. Routine immunologic function evaluation in 74 BCGosis/BCGitis patients.

	without PID* (n = 42)	with CGD* (n = 23)	with HIGM* (n = 2)	with HIES* (n = 1)	with SCID* (n = 2)	with MSMD* (n = 4)
Lymphocyte subsets
CD3+(%)	51–77	55–71	82; 72	94	9; 11	48–57
CD3+CD4+(%)	35–55	23–44	21; 22	52	4; 3	29–27
CD3+CD8+(%)	13–36	31–45	49; 45	27	4; 4	17–27
CD16+CD56+(%)	5–35	8–17	15; 17	2	2.5; 3.2	6–7
CD19+(%)	3–17	7–21	3; 5	4	65; 71	40–31
Immunoglobulin level
IgG(g/L)	3.7–24.8	8.6–26	1.2; 1.75	24.6	0.98; 0.57	7.2–11.3
IgA(g/L)	0.1–2.24	0.81–3.02	1.28; 2.49	0.38	0.067; 0.03	0.23–0.98
IgM(g/L)	0.09–3.24	1.02–3.27	6.76; 55.34	3.08	0.04; 0.02	0.24–1.57
IgE(kU/L)	2.6–390	24.5–990	<2; 3.96	129000	<2	7.14–206
DHR analysis# (SI*)	>100	<10	>100	>100	>100	>100

*PID: primary immunodeficiency disease; CGD: chronic granulomatous disease; HIGM: hyper IgM syndrome; HIES: hyper IgE syndrome; MSMD: Mendelian susceptibility to mycobacterial diseases. SI: stimulation index.

^#DHR analysis: The comparison was based on a stimulation index, which was defined as mean channel fluorescence intensity of PMA-stimulated neutrophils over mean channel fluorescence intensity of unstimulated neutrophils.